231 related articles for article (PubMed ID: 22664956)
1. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
[TBL] [Abstract][Full Text] [Related]
2. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
[TBL] [Abstract][Full Text] [Related]
3. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
Straznicky NE; Lambert GW; Masuo K; Dawood T; Eikelis N; Nestel PJ; McGrane MT; Mariani JA; Socratous F; Chopra R; Esler MD; Schlaich MP; Lambert EA
Am J Clin Nutr; 2009 Jan; 89(1):27-36. PubMed ID: 19056585
[TBL] [Abstract][Full Text] [Related]
4. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.
Straznicky NE; Lambert GW; McGrane MT; Masuo K; Dawood T; Nestel PJ; Eikelis N; Schlaich MP; Esler MD; Socratous F; Chopra R; Lambert EA
Diabetes; 2009 May; 58(5):1126-32. PubMed ID: 19188428
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
[TBL] [Abstract][Full Text] [Related]
7. β-Cell dysfunction is associated with metabolic syndrome severity in adults.
Malin SK; Finnegan S; Fealy CE; Filion J; Rocco MB; Kirwan JP
Metab Syndr Relat Disord; 2014 Mar; 12(2):79-85. PubMed ID: 24283920
[TBL] [Abstract][Full Text] [Related]
8. Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.
Straznicky NE; Grima MT; Lambert EA; Sari CI; Eikelis N; Nestel PJ; Phillips SE; Hering D; Karapanagiotidis S; Dixon JB; Schlaich MP; Lambert GW
J Clin Endocrinol Metab; 2015 Apr; 100(4):1544-50. PubMed ID: 25590214
[TBL] [Abstract][Full Text] [Related]
9. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
[TBL] [Abstract][Full Text] [Related]
10. Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss.
Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Mariani JA; Kobayashi D; Hering D; Dixon JB; Lambert GW
Front Physiol; 2016; 7():516. PubMed ID: 27857694
[No Abstract] [Full Text] [Related]
11. Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
Frontoni S
Diabetes; 2013 Jan; 62(1):e1. PubMed ID: 23258917
[No Abstract] [Full Text] [Related]
12. Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
Straznicky NE; Lambert EA; Lambert GW
Diabetes; 2013 Jan; 62(1):e2. PubMed ID: 23258918
[No Abstract] [Full Text] [Related]
13. The role of increased glucose on neurovascular dysfunction in patients with the metabolic syndrome.
Rodrigues S; Cepeda FX; Toschi-Dias E; Dutra-Marques ACB; Carvalho JC; Costa-Hong V; Alves MJNN; Rondon MUPB; Bortolotto LA; Trombetta IC
J Clin Hypertens (Greenwich); 2017 Sep; 19(9):840-847. PubMed ID: 28868764
[TBL] [Abstract][Full Text] [Related]
14. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes.
George L; Bacha F; Lee S; Tfayli H; Andreatta E; Arslanian S
J Clin Endocrinol Metab; 2011 Jul; 96(7):2136-45. PubMed ID: 21508130
[TBL] [Abstract][Full Text] [Related]
15. Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake.
Baqar S; Straznicky NE; Lambert G; Kong YW; Dixon JB; Jerums G; Ekinci EI; Lambert E
BMJ Open Diabetes Res Care; 2019; 7(1):e000606. PubMed ID: 31114697
[TBL] [Abstract][Full Text] [Related]
16. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
Henninger J; Hammarstedt A; Rawshani A; Eliasson B
BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
[TBL] [Abstract][Full Text] [Related]
17. Pre-diabetes in Italian obese children and youngsters.
Brufani C; Fintini D; Ciampalini P; Nocerino V; Crea F; Giannone G; Patera PI; Valerio G; Cappa M; Barbetti F
J Endocrinol Invest; 2011 Oct; 34(9):e275-80. PubMed ID: 21666412
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects.
Schumann U; Jenkinson CP; Alt A; Zügel M; Steinacker JM; Flechtner-Mors M
PLoS One; 2017; 12(3):e0173803. PubMed ID: 28346464
[TBL] [Abstract][Full Text] [Related]
19. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.
Gudbjörnsdottir S; Friberg P; Elam M; Attvall S; Lönnroth P; Wallin BG
Blood Press; 1994 Nov; 3(6):394-403. PubMed ID: 7704288
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
